Skip to content

Paul Loadman

Professor

Area
Institute of Cancer Therapeutics
Faculty of Life Sciences
E-mail
Phone
Paul Loadman

Biography

Pharmacokinetics and tumour drug metabolism of anti-cancer drugs
Professor Paul Loadman heads the drug metabolism team at the Institute of Cancer Therapeutics, University of Bradford and has >20years experience studying the pharmacokinetics and metabolism of anti-cancer drugs. The team in Bradford have studied a wide range of clinically available and novel small molecules including antimetabolites, platinating and alkylating agents, peptides and antivascular compounds. Prof Loadman is actively involved in the design, analysis and reporting of pre-clinical and clinical pharmacokinetic studies and acts as a pharmacokinetic and drug metabolism consultant for numerous pharmaceutical and biotechnology companies. Together with Prof Twelves (Clinical Director,) the DMPK team have established a Quality Management System within the ICT which has enabled a strong involvement in the pharmacokinetic monitoring of small molecules in major clinical trials. Other major clinical collaborations include with Professor Mark Hull at the University of Leeds (The seAFOod Polyp Prevention Trial, www.seafood-trial.co.uk) where the laboratory in Bradford are analyzing a series of bioactive lipid mediators such as ω-3 PUFAs, resolvin E1 and PGE-M in plasma, urine, erythrocytes and rectal mucosa in order to gain insights into the mechanism of action of EPA and aspirin.

Research

  • Pharmacokinetics and tumour drug metabolism of anti cancer drugs
  • Matrix metalloproteinases as targets for tumour-selective delivery of anticancer therapeutics
  • Drug delivery and prodrug design
  • Novel advances in analytical techniques. HPLC, GC, CE and LC/MS/MS
  • Drug interactions both in vitro and in vivo

Professional activities

  • University of Bradford - PhD

  • Royal Society of Biology , Royal Society of Biology
  • Drug Metabolism Discussion Group (DMDG), Drug Metabolism Discussion Group (DMDG)
  • Pharmacokinetics and Molecular Mechanisms (PAMM) Group, Pharmacokinetics and Molecular Mechanisms (PAMM) Group
  • European Association for Cancer Research , European Association for Cancer Research
  • American Association for Cancer Research , American Association for Cancer Research
  • British Association for Cancer Research , British Association for Cancer Research

Publications